Table 2 Laboratory data and numbers of patients on therapy to normalize thyroid parameters in MNG out-patients treated with RAI with (group 1) or without (group 2) rhTSH pre-treatment (0.1 mg, on two consecutive days).
Group 1 | Group 2 | Significance | |
|---|---|---|---|
TSH (mIU/l) | 1.61 ± 0.19 | 1.36 ± 0.19 | ns |
f-T3 (pmol/l) | 4.0 ± 0.1 | 4.6 ± 0.1 | P = 0.001 |
f-T4 (pmol/l) | 15.3 ± 0.5 | 14.7 ± 0.6 | ns |
Tg (μg/l) | 168.3 ± 50.4 | 337.7 ± 268.7 | ns |
Positive thyroid antibodies (n) | 5 | 3 | ns |
L-T4 treatment (n) | 12 | 3 | P = 0.002 |
MMI treatment (n) | 0 | 2 | ns |